HOMOLOGY MEDICINES INC (FIXX)
US4380831077 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 749.00K | 0.00 | 100.00K | 300.00K | 300.00K | |||
| Cash Equivalents | 38.52M | 34.00M | 108.30M | 217.20M | 39.50M | |||
| Marketable Securities | 43.39M | 141.00M | 47.50M | 0.00 | 222.60M | |||
| Other Current Assets | 1.26M | 6.00M | 36.00M | 2.10M | 4.20M | |||
| Total Current Assets | 83.91M | 181.00M | 191.90M | 219.60M | 266.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 650.00K | 21.60M | 17.90M | 42.90M | 42.70M | |||
| Investments And Advances | 0.00 | 25.80M | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | 0.00 | 2.00M | 1.30M | 1.30M | |||
| Total Non-Current Assets | 650.00K | 47.50M | 19.80M | 44.10M | 44.00M | |||
| TOTAL ASSETS | 84.56M | 228.50M | 211.70M | 263.70M | 310.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.34M | 20.30M | 11.70M | 12.30M | 7.60M | |||
| Accounts Payable | 3.23M | 1.10M | 2.40M | 4.70M | 2.60M | |||
| Other Current Liabilities | 0.00 | 1.20M | 3.20M | 5.60M | 2.10M | |||
| Total Current Liabilities | 11.57M | 22.60M | 17.20M | 22.70M | 12.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 27.90M | 24.80M | 45.10M | 39.70M | |||
| Total Non-Current Liabilities | 0.00 | 27.90M | 24.90M | 45.00M | 39.70M | |||
| TOTAL LIABILITIES | 11.57M | 50.50M | 42.10M | 67.70M | 52.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -542.10M | -429.10M | -424.10M | -328.40M | -199.70M | |||
| Additional Paid In Capital | 615.09M | 607.50M | 593.80M | 524.40M | 458.00M | |||
| Common Shares | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 58.02M | 57.50M | 57.20M | 50.30M | 45.10M | |||
| Tangible Book Value per Share | 1.26 | 3.10 | 2.97 | 3.90 | 5.73 | |||
| Total Shareholders' Equity | 72.99M | 178.00M | 169.70M | 196.00M | 258.50M | |||
| TOTAL LIABILITIES AND EQUITY | 84.56M | 228.50M | 211.70M | 263.70M | 310.60M | |||
| Statistics | ||||||||
| Current Ratio | 7.25 | 8.01 | 11.16 | 9.67 | 21.50 | |||
| Return On Assets (ROA) | -133.58% | -2.19% | -45.23% | -48.80% | -33.46% | |||
| Return On Equity (ROE) | -154.76% | -2.81% | -56.43% | -65.66% | -40.20% | |||
All data in USD